FDA 483 - SMS Pharmaceutical Limited - Unit VII - January 17, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
SMS Pharmaceuticals Limited, Unit-VII, an API manufacturer in Vizianagaram District, India, was cited for significant deficiencies during an FDA inspection. The inspection revealed that the quality control unit failed to adequately follow procedures for Out-of-Specification (OOS) investigations and complaint handling. Additionally, the firm's laboratory control mechanisms were found to be inadequate, particularly concerning method accuracy assessments for cleaning validation.
ID · bed084bf-f3ef-4526-ac39-42dbdf4ac7a7